Why Insulin Infusion Must Continue Despite Low Blood Glucose in DKA and HHS
Insulin infusion must be continued even when blood glucose becomes low in DKA and HHS because the primary goal is to resolve the underlying metabolic crisis—clearing ketones in DKA and correcting hyperosmolality in HHS—not simply lowering glucose. 1
The Core Pathophysiology
The fundamental problem in both DKA and HHS extends beyond hyperglycemia. In DKA, insulin deficiency triggers uncontrolled lipolysis and ketogenesis, producing life-threatening ketoacidosis 2. In HHS, severe hyperosmolality develops from profound dehydration and hyperglycemia 2. Stopping insulin prematurely—even when glucose normalizes—allows these dangerous metabolic processes to resume.
Why Glucose Drops Faster Than the Crisis Resolves
Blood glucose responds rapidly to insulin and fluid resuscitation, typically falling at 50-75 mg/dL per hour 3. However, the resolution of ketoacidosis (achieving bicarbonate >15 mEq/L, pH >7.3, anion gap <12) and correction of hyperosmolality (osmolality <315 mOsm/kg) take substantially longer 1. This creates a critical window where glucose may reach 150-250 mg/dL while the patient remains in metabolic crisis.
The Management Algorithm When Glucose Becomes Low
For DKA:
- When glucose falls to 200 mg/dL: Add dextrose-containing IV fluids (D5W or D10W) alongside continued 0.9% saline 1
- Maintain glucose between 150-200 mg/dL until ketoacidosis resolves 1
- Continue insulin infusion at the same or reduced rate (consider decreasing from 0.1 to 0.05 units/kg/h if glucose <140 mg/dL) 3
- Do not stop insulin until: bicarbonate >15 mEq/L, pH >7.3, anion gap normalized, and patient able to eat 1
For HHS:
- When glucose falls to 250 mg/dL: Add dextrose-containing fluids 1
- Target glucose 200-250 mg/dL until hyperosmolality resolves 1
- Continue insulin until calculated osmolality falls to <315 mOsm/kg 1
Critical Pitfalls to Avoid
The most dangerous error is premature discontinuation of IV insulin 4. This leads to:
- Rebound ketoacidosis in DKA patients, requiring readmission 5, 4
- Recurrent hyperosmolality in HHS 4
- Increased mortality and morbidity 4
The Transition Protocol
When the metabolic crisis has resolved AND the patient can eat:
- Give subcutaneous basal insulin 2-4 hours before stopping IV insulin 5, 1
- Continue IV insulin during this overlap period to prevent metabolic relapse 5, 1
- Recent evidence suggests adding low-dose basal insulin analog during the IV infusion may prevent rebound hyperglycemia without increasing hypoglycemia risk 5
Additional Monitoring Considerations
While maintaining insulin infusion with low glucose:
- Monitor potassium closely (every 2-4 hours)—insulin drives potassium intracellularly, and hypokalemia can cause fatal arrhythmias 1, 6
- Maintain potassium 4-5 mEq/L with aggressive replacement 1
- Check glucose every 1-2 hours to titrate dextrose infusion 1
- Monitor pH, bicarbonate, anion gap, and osmolality every 2-4 hours until stable 1
The Evidence Base
The most recent ADA Standards of Care (2024-2025) provide the highest-quality guidance 5, 1. These guidelines emphasize that resolution criteria are metabolic, not glycemic. The 2022 Joint British Diabetes Society guideline 3 specifically addresses the high prevalence of hypoglycemia when insulin is continued, recommending de-escalation to 0.05 units/kg/h when glucose drops below 250 mg/dL (14 mmol/L), but not cessation.
The key principle: insulin's role in DKA/HHS is to shut down ketogenesis and restore cellular glucose uptake—not merely to lower blood glucose. Dextrose infusion allows you to maintain this therapeutic insulin effect while preventing hypoglycemia, ensuring complete metabolic recovery and preventing the high mortality associated with premature treatment discontinuation.